Packaged foods company Kellanova (NYSE:K) met Wall Street’s revenue expectations in Q4 CY2024, but sales fell by 1.6% year on ...

Emcure Pharmaceuticals on Thursday reported a 30.3% year-on-year (YoY) increase in net profit to Rs.156 crore in Q3FY25 led ...

Robust revenue growth Strengthened momentum across all business segments Fourth quarter and full year operating highlights: Three months ended Twelve months ended December 31 December 31(in millions ...

Revenue in Q4 2024 increased 45% to $13.53 billion driven by volume growth from Mounjaro and Zepbound. Non-incretin revenue(i) grew by 20% compared to Q4 2023. Pipeline ...